J&J CFO on Earnings, Immunology Portfolio and Pricing Pressure

The video discusses Johnson & Johnson's performance, focusing on oncology and immunology's role in driving results. It addresses the impact of biosimilars and generics, portfolio management strategies, and pricing trends. The company navigates challenges like competition and legislative pressures while maintaining growth and innovation.

What impact has the so-called 'Donut Hole' had on Johnson & Johnson's finances?

How has pricing for Johnson & Johnson products changed over the last few years?

What are the expectations regarding future pricing pressures in the pharmaceutical industry?